WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Operating Expenses Over TimeStable
Percentile Rank7
3Y CAGR-4.8%
5Y CAGR-4.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-4.8%/yr
vs -9.2%/yr prior
5Y CAGR
-4.6%/yr
Consistent
Acceleration
+4.5pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.72B | +1.4% |
| 2024 | $7.62B | -2.2% |
| 2023 | $7.79B | -12.8% |
| 2022 | $8.94B | -7.4% |
| 2021 | $9.65B | -1.4% |
| 2020 | $9.78B | -17.4% |
| 2019 | $11.85B | -10.0% |
| 2018 | $13.16B | -9.3% |
| 2017 | $14.51B | -5.5% |
| 2016 | $15.36B | - |